[1] Tan, D. X., Korkmaz, A., Reiter, R. J., & Manchester, L. C. (2014).

Ebola virus disease:

potential use of melatonin as a treatment. Journal of pineal research, 57(4), 381-384.
[2] Hernandez-Ruiz, J., Cano, A., & Arnao, M. B. (2004). Melatonin: a growth-stimulating
compound present in lupin tissues. Planta, 220(1), 140-144.
[3] Manchester, L. C., Tan, D. X., Reiter, R. J., Park, W., Monis, K., & Qi, W. (2000). High
levels of melatonin in the seeds of edible plants: possible function in germ tissue
protection. Life sciences, 67(25), 3023-3029.
[4] Kol, J., & Machkov, I. (2005). Melatonin in higher plants: occurrence and possible
functions. Journal of pineal research, 39(4), 333-341.
[5] Brusco, L. I., Mrquez, M., & Cardinali, D. P. (1998). Monozygotic twins with
Alzheimer's disease treated with melatonin: Case report. Journal of pineal
research, 25(4), 260-263.
[6] Ebola Factsheet. Centers for Disease Control and Prevention, 2014 [cited Oct 17, 2014].
Available from: http://www.cdc. gov/vhf/ebola/pdf/ebola-factsheet.pdf
[7] Peterson AT, Bauer JT, Mills JN. Ecologic and geographic distribution of ilovirus disease.
Emerg Infect Dis. 2004;10:40-7.
[8] Groseth A, Feldmann H, Strong JE. The ecology of Ebola virus. Trends Microbiol.
2007;15:408-16.
[9] Arellanos-soto, D. (2016). medicina universitaria, 16(65), 207215.

[10] Ramkumar, P., & Suresh, B. (2015). Quantum of Ebola Virus Disease Occurrence and
Quantum of Research Publications: A Scientrometric Analysis,
8(July).https://doi.org/10.17485/ijst/2015/v8i14/70707
[11] Abbet, P., Procopiou, M., Genne, D., Defabiani, N., & Auckenthaler, R. (1998). Marburg
and Ebola Hemorrhagic Fevers: Does the UC: CID, 27, 404406

[12] Ryabchikova E, Kolesnikova L, Smolina M, et al. Ebola virus infection in

guinea pigs: presumable role of granulomatous in- lammation in pathogenesis.
Arch Virol. 1996;141:909-21.

[13] Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of
prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis. 1998;178:651-61
[14] Connolly BM, Steele KE, Davis KJ, et al. Pathogenesis of experimental Ebola virus
infection in guinea pigs. J Infect Dis. 1999;179 Suppl 1:S203-17

[15] Bray M, Hatill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation
changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of
Ebola Zaire virus. J Comp Pathol. 2001;125:243-53

[16] Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Evaluation in
nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis. 2002;8:503-7
[17] Twenhafel NA, Mattix ME, Johnson JC, et al. Pathology of experimental aerosol Zaire
ebolavirus infection in rhesus macaques. Vet Pathol 2013; 50, 514-529

[18] Hensley LE, Geisbert TW. The contribution of the endothelium to the development of
coagulation disorders that characterize Ebola hemorrhagic fever in primates. Thromb
Haemost 2005; 94, 254-261

[19] Hensley LE, Young HA, Jahrling PB, et al. Proinflammatory response during Ebola virus
infection of primate models: possible involvement of the tumor necrosis factor receptor
superfamily. Immunol Lett 2002; 80,169-179.

[20] Martinez O, Valmas C, Basler CF. Ebola virus-like particle-induced activation of NF-
kappaB and Erk signaling in human dendritic glycoprotein mucin domain. Virology 2007;
364, 342-354.

[21] Geisbert TW, Hensley LE, Jahrling PB et al. Treatment of Ebola virus infection with a
recombinantinhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet
2003; 362,19531958.
[22] Zaki SR, Shieh WJ, Greer PW, et al. A novel immunohistochemical assay for the
detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of
Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect
Dis. 1999;179 Suppl 1:S36-47.
[23] Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in
cynomolgus macaques: evidence that dendritic cells are early and sustained targets of
infection. Am J Pathol. 2003;163:2347-70.
[24] Jaax NK, Davis KJ, Geisbert TJ, et al. Lethal experimental infection of rhesus
monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of
exposure. Arch Pathol Lab Med. 1996;120:140-55.

[25] Geisbert TW, Young HA, Jahrling PB, et al. Pathogenesis of Ebola hemorrhagic fever in
primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis
of en- dothelial cells. Am J Pathol. 2003;163:2371-82.

[26] Schnittler HJ, Feldmann H. Marburg and Ebola hemorrhagic fevers: does the primary
course of infection depend on the ac- cessibility of organ-specific macrophages? Clin
Infect Dis. 1998;27:404-6.

[27] Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377:849-62.

[28] Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr
Top Microbiol Immunol. 1999;235:97-116.

[29] Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the
Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and
injury. Nat Med. 2000;6:886-9.

[30] Murphy F. Pathogenesis of Ebola virus infection. In: Pattyn S, editor. Ebola virus
haemorrhagic fever. Amsterdam: Elsevier/ North-Holland; 1978. p. 43-9.

[31] Sanchez A, Geisbert T, Feldmann H. Filoviridae: Marburg and Ebola Viruses. In: Knipe
D, Howley P, editors. Fields virology. 5th ed. Philadelphia: Lippincott Williams &
Walkins; 2007. p. 1409-48.

[32] Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus infection. Br Med J.
1977;2:541-4.

[33] Hensley LE, Young HA, Jahrling PB, Geisbert TW. Proinlammatory response during
Ebola virus infection of primate models: possible involvement of the tumor necrosis
factor receptor su- perfamily. Immunol Lett. 2002;80:169-79.
[34] Ryabchikova EI, Kolesnikova LV, Luchko SV. An analysis of features of pathogenesis in
two animal models of Ebola virus infection. J Infect Dis. 1999;179 Suppl 1:S199-202.

[35] Stehle, J. H., Saade, A., Rawashdeh, O., Ackermann, K., Jilg, A., Sebestny, T., &
Maronde, E. (2011). A survey of molecular details in the human pineal gland in the light
of phylogeny, structure, function and chronobiological diseases. Journal of pineal
research, 51(1), 17-43.

[36] Hardeland, R., Madrid, J. A., Tan, D. X., & Reiter, R. J. (2012). Melatonin, the circadian
multioscillator system and health: the need for detailed analyses of peripheral melatonin
signaling. Journal of pineal research, 52(2), 139-166.
[37] Cuzzocrea, S., & Reiter, R. J. (2002). Pharmacological actions of melatonin in acute and
chronic inflammation. Current topics in medicinal chemistry, 2(2), 153-165.
[38] Gitto, E., Karbownik, M., Reiter, R. J., Tan, D. X., Cuzzocrea, S., Chiurazzi, P., &
Barberi, I. (2001). Effects of melatonin treatment in septic newborns. Pediatric
Research, 50(6), 756-760.
[39] Bertuglia, S., Marchiafava, P. L., & Colantuoni, A. (1996). Melatonin prevents ischemia
reperfusion injury in hamster cheek pouch microcirculation. Cardiovascular
research, 31(6), 947-952.
[40] Alamili, M., Bendtzen, K., Lykkesfeldt, J., Rosenberg, J., & Ggenur, I. (2014).
Melatonin suppresses markers of inflammation and oxidative damage in a human
daytime endotoxemia model. Journal of critical care, 29(1), 184-e9.
[41] Song, J., Kang, S. M., Lee, W. T., Park, K. A., Lee, K. M., & Lee, J. E. (2014). The
beneficial effect of melatonin in brain endothelial cells against oxygen-glucose
deprivation followed by reperfusion-induced injury. Oxidative medicine and cellular
longevity, 2014.
[42] Kostovski, E., Dahm, A. E., Iversen, N., Hjeltnes, N., sterud, B., Sandset, P. M., &
Iversen, P. O. (2011). Melatonin stimulates release of tissue factor pathway inhibitor from
the vascular endothelium. Blood Coagulation & Fibrinolysis, 22(4), 254-259.
[43] Cuzzocrea, S., & Reiter, R. J. (2002). Pharmacological actions of melatonin in acute and
chronic inflammation. Current topics in medicinal chemistry, 2(2), 153-165.
[44] Cuzzocrea, S., Zingarelli, B., Costantino, G., & Caputi, A. R. (1998). Protective effect of
melatonin in a nonseptic shock model induced by zymosan in the rat. Journal of pineal
research, 25(1), 24-33.
[45] Cuzzocrea, S., Zingarelli, B., Gilad, E., Hake, P., Salzman, A. L., & Szabo, C. (1997).
Protective effect of melatonin in carrageenaninduced models of local inflammation:
relationship to its inhibitory effect on nitric oxide production and its peroxynitrite
scavenging activity. Journal of pineal research, 23(2), 106-116.
[46] Gilad, E., Wong, H. R., Zingarelli, B., Virg, L., O'Connor, M., Salzman, A. L., & Szab,
C. (1998). Melatonin inhibits expression of the inducible isoform of nitric oxide synthase
in murine macrophages: role of inhibition of NFB activation. The FASEB
Journal, 12(9), 685-693.
[47] Lezoualc'h, F., Sparapani, M., & Behl, C. (1998). Nacetylserotonin (normelatonin) and
melatonin protect neurons against oxidative challenges and suppress the activity of the
transcription factor NFB. Journal of pineal research, 24(3), 168-178.
[48] Pozo, D., Reiter, R. J., Calvo, J. R., & Guerrero, J. M. (1994). Physiological
concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life
sciences, 55(24), PL455-PL460.
[49] Bettahi, I., Pozo, D., Osuna, C., Reiter, R. J., AcuaCastroviejo, D., & Guerrero, J. M.
(1996). Melatonin reduces nitric oxide synthase activity in rat hypothalamus. Journal of
pineal research, 20(4), 205-210.
[50] Cuzzocrea, S., Costantino, G., Mazzon, E., & Caputi, A. P. (1999). Regulation of
prostaglandin production in carrageenaninduced pleurisy melatonin. Journal of pineal
research, 27(1), 9-14.
[51] Boga, J. A., CotoMontes, A., RosalesCorral, S. A., Tan, D. X., & Reiter, R. J. (2012).
Beneficial actions of melatonin in the management of viral infections: a new use for this
molecular handyman?. Reviews in medical virology, 22(5), 323-338.
[52] Maestroni, G. J. M., Conti, A., & Pierpaoli, W. (1986). Circadian synthesis and release of
melatonin modulates the antibody response and antagonizes the immunosuppressive
effect of corticosterone. J. Neuroimmunol, 13, 19-30.
[53] Barlow-Walden, L. R., Reiter, R. J., Abe, M., Pablos, M., Menendez-Pelaez, A., Chen, L.
D., & Poeggeler, B. (1995). Melatonin stimulates brain glutathione peroxidase
activity. Neurochemistry international, 26(5), 497-502.
[54] Pablos, M. I., Reiter, R. J., Ortiz, G. G., Guerrero, J. M., Agapito, M. T., Chuang, J. I., &
Sewerynek, E. (1998). Rhythms of glutathione peroxidase and glutathione reductase in
brain of chick and their inhibition by light. Neurochemistry international, 32(1), 69-75.
[55] Li, Z. R., Reiter, R. J., Fujimori, O., Oh, C. S., & Duan, Y. P. (1997). Cataractogenesis
and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive
actions of melatonin. Journal of pineal research, 22(3), 117-123.
[56] Kim, S. J., Reiter, R. J., Garay, M. V. R., Qi, W., El-Sokkary, G. H., & Tan, D. X. (1998).
2-Nitropropane-induced lipid peroxidation: antitoxic effects of
melatonin. Toxicology, 130(2), 183-190.
[57] Axelrod, J., & Weissbach, H. (1960). Enzymatic O-methylation of N-acetylserotonin to
melatonin. Science, 131(3409), 1312-1312.
[58] Cano, A., Alcaraz, O., & Arnao, M. B. (2003). Free radical-scavenging activity of indolic
compounds in aqueous and ethanolic media. Analytical and bioanalytical
chemistry, 376(1), 33-37.
[59] Pape, C., & Lning, K. (2006). Quantification of melatonin in phototrophic
organisms. Journal of pineal research, 41(2), 157-165.
[60] Cao, J., Murch, S. J., OBrien, R., & Saxena, P. K. (2006). Rapid method for accurate
analysis of melatonin, serotonin and auxin in plant samples using liquid chromatography
tandem mass spectrometry. Journal of Chromatography A, 1134(1), 333-337.
[61] Tan, D. X., Manchester, L. C., Reiter, R. J., Qi, W., Hanes, M. A., & Farley, N. J. (1999).
High physiological levels of melatonin in the bile of mammals. Life sciences, 65(23),
2523-2529.
[62] Brun, J., Claustrat, B., Saddier, P., & Chazot, G. (1995). Nocturnal melatonin excretion is
decreased in patients with migraine without aura attacks associated with
menses. Cephalalgia, 15(2), 136-139.
[63] Bubenik, G. A., Hacker, R. R., Brown, G. M., & Bartos, L. (1999). Melatonin
concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine
gastrointestinal tract. Journal of pineal research, 26(1), 56-63.